BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35695136)

  • 1. Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry.
    Gao T; Lott AA; Huang F; Rohokale R; Li Q; Olivos HJ; Chen S; Guo Z
    Analyst; 2022 Jun; 147(13):3101-3108. PubMed ID: 35695136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Mobility Mass Spectrometry Reveals Rare Sialylated Glycosphingolipid Structures in Human Cerebrospinal Fluid.
    Sarbu M; Fabris D; Vukelić Ž; Clemmer DE; Zamfir AD
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry in combination with a chiral column and multichannel-MRM allows comprehensive analysis of glycosphingolipid molecular species from mouse brain.
    Fujiwara Y; Hama K; Yokoyama K
    Carbohydr Res; 2020 Apr; 490():107959. PubMed ID: 32120021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Database and data analysis application for structural characterization of gangliosides and sulfated glycosphingolipids by negative ion mass spectrometry.
    Rožman M; Fabris D; Mrla T; Vukelić Ž
    Carbohydr Res; 2014 Dec; 400():1-8. PubMed ID: 25299937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells.
    Anugraham M; Everest-Dass AV; Jacob F; Packer NH
    Rapid Commun Mass Spectrom; 2015 Apr; 29(7):545-61. PubMed ID: 26212272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Spectrometry of Neutral Glycosphingolipids.
    Suzuki A; Silsirivanit A; Watanabe T; Matsuda J; Inamori KI; Inokuchi JI
    Methods Mol Biol; 2023; 2613():127-144. PubMed ID: 36587076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography-ion mobility spectrometry-mass spectrometry analysis of multiple classes of steroid hormone isomers in a mixture.
    Rister AL; Dodds ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121941. PubMed ID: 31877426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Glycosphingolipids and Their Diverse Lipid Forms through Two-Stage Matching of LC-MS/MS Spectra.
    Bailey LS; Huang F; Gao T; Zhao J; Basso KB; Guo Z
    Anal Chem; 2021 Feb; 93(6):3154-3162. PubMed ID: 33534538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosphingolipid structural analysis and glycosphingolipidomics.
    Levery SB
    Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online Ozonolysis Combined with Ion Mobility-Mass Spectrometry Provides a New Platform for Lipid Isomer Analyses.
    Poad BLJ; Zheng X; Mitchell TW; Smith RD; Baker ES; Blanksby SJ
    Anal Chem; 2018 Jan; 90(2):1292-1300. PubMed ID: 29220163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated normal phase nano high performance liquid chromatography/matrix assisted laser desorption/ionization mass spectrometry for analysis of neutral and acidic glycosphingolipids.
    Zarei M; Kirsch S; Müthing J; Bindila L; Peter-Katalinić J
    Anal Bioanal Chem; 2008 May; 391(1):289-97. PubMed ID: 18327675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Localization of Glycosphingolipid Accumulation in a Gaucher Disease Mouse Brain by LC-ESI-MS/MS and High-Resolution MALDI Imaging Mass Spectrometry.
    Jones EE; Zhang W; Zhao X; Quiason C; Dale S; Shahidi-Latham S; Grabowski GA; Setchell KDR; Drake RR; Sun Y
    SLAS Discov; 2017 Dec; 22(10):1218-1228. PubMed ID: 28714776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific characterization of (D)-amino acid containing peptide epimers by ion mobility spectrometry.
    Jia C; Lietz CB; Yu Q; Li L
    Anal Chem; 2014 Mar; 86(6):2972-81. PubMed ID: 24328107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides of Human Glioblastoma Multiforme: A Comprehensive Mapping and Structural Analysis by Ion Mobility Tandem Mass Spectrometry.
    Sarbu M; Petrica L; Clemmer DE; Vukelić Ž; Zamfir AD
    J Am Soc Mass Spectrom; 2021 May; 32(5):1249-1257. PubMed ID: 33900081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory.
    Dubland JA
    J Mass Spectrom Adv Clin Lab; 2022 Jan; 23():7-13. PubMed ID: 34988541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a new vitamin D blood test on the Emirati population.
    Shah I; Al-Dabbagh B; Gariballa S; Al-Menhali A; Muhammad N; Yasin J; Ashraf SS
    J Steroid Biochem Mol Biol; 2018 Jun; 180():118-128. PubMed ID: 29432962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of glycosphingolipid epimers by radical-directed dissociation mass spectrometry.
    Pham HT; Julian RR
    Analyst; 2016 Feb; 141(4):1273-8. PubMed ID: 26800360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Analysis of Isomeric Polyphenol Dimers Using the 4th Dimension of Trapped Ion Mobility Spectrometry-Mass Spectrometry.
    de Sousa Dias AL; Verbaere A; Meudec E; Deshaies S; Saucier C; Cheynier V; Sommerer N
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Skyline to analyze lipidomics data containing liquid chromatography, ion mobility spectrometry and mass spectrometry dimensions.
    Kirkwood KI; Pratt BS; Shulman N; Tamura K; MacCoss MJ; MacLean BX; Baker ES
    Nat Protoc; 2022 Nov; 17(11):2415-2430. PubMed ID: 35831612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
    Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
    Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.